Safety, Reactogenicity, and Immunogenicity of Inactivated Influenza A/H7/N7 Vaccine in Healthy Adults

NCT00546585 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

126

Enrollment

NIH

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: Influenza A/H7N7 Vaccine
DRUG: Placebo

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)